First-Generation Epidermal Growth Factor Receptor Inhibitors Plus Antiangiogenic Drugs Versus Third-Generation Epidermal Growth Factor Receptor Inhibitors in Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis.
Mirta MoscaNicole ConciAlessandro Di FedericoValentina TateoValentina FavoritoArianna ZappiFrancesco GelsominoAndrea De GiglioPublished in: JCO precision oncology (2023)
mutations.